Skip to main content
Black Friday Sale - Get 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

PharmaCorp Announces Executive Transition and New Director of Business Development

PharmaCorp aims to expand by acquiring pharmacies under PharmaChoice Canada as leadership changes target growth and strategic operations, the company said.

Summary by Benzinga
SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV:PCRX) today announced an executive transition in which Paul Dale has been appointed President and

8 Articles

BenzingaBenzinga
+7 Reposted by 7 other sources
Center

PharmaCorp Announces Executive Transition and New Director of Business Development

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. ("PharmaCorp" or the "Corporation") (TSXV:PCRX) today announced an executive transition in which Paul Dale has been appointed President and

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, November 28, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Saskatoon icon

Saskatoon

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal